Remission Induction | List of Frontiers open access articles

Systematic Review

Published on 01 Mar 2021

The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis

in Rheumatology

Anji Xiong
Chen Xiong
Guancui Yang
Yu Shuai
Deng Liu
Linqian He
Zepeng Guo
Liangwen Zhang
Yi Liu
Yuan Yang

Frontiers in Medicine

doi 10.3389/fmed.2021.609924

6,081 views
10 citations

Original Research

Published on 09 Nov 2020

Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice

in Computational Genomics

Bin Li
Yanlai Tang
Xuhao Ni
Wei Chen

Frontiers in Genetics

doi 10.3389/fgene.2020.577040

5,326 views
3 citations

Original Research

Published on 12 Feb 2026

Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseases

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Hideki Oka
Shuji Sumitomo
Chisato Miyakoshi
Koichiro Ohmura

Frontiers in Immunology

doi 10.3389/fimmu.2026.1696516

516 views

Brief Research Report

Published on 09 Feb 2021

Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment

in Nephrology

Samy Hakroush
Desiree Tampe
Peter Korsten
Philipp Ströbel
Michael Zeisberg
Björn Tampe

Frontiers in Medicine

doi 10.3389/fmed.2020.622028

4,112 views
16 citations

Brief Research Report

Published on 14 Jun 2022

The Growing Spectrum of DADA2 Manifestations—Diagnostic and Therapeutic Challenges Revisited

in Pediatric Immunology

Carolin Escherich
Benedikt Bötticher
Stefani Harmsen
Marc Hömberg
Jörg Schaper
Myriam Ricarda Lorenz
Klaus Schwarz
Arndt Borkhardt
Prasad Thomas Oommen

Frontiers in Pediatrics

doi 10.3389/fped.2022.885893

5,537 views
8 citations

Review

Published on 18 Mar 2014

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia

in Pediatric Oncology

Sarah K Tasian
Jessica A Pollard
Richard Aplenc

Frontiers in Oncology

doi 10.3389/fonc.2014.00055

14,487 views
40 citations

Original Research

Published on 07 Jun 2022

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children’s Cancer Group

in Hematologic Malignancies

Yong Zhuang
Kefei Wu
Xiaofan Zhu
Jiaoyang Cai
Shaoyan Hu
Ju Gao
Hua Jiang
Xiaowen Zhai
Xin Tian
Yongjun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.911567

13,166 views
3 citations

Case Report

Published on 25 Aug 2025

Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case report

in Hematologic Malignancies

Kaikai Huang
Yanbin Pang

Frontiers in Oncology

doi 10.3389/fonc.2025.1628767

3,033 views
1 citation

Original Research

Published on 11 May 2022

A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients

in Hematologic Malignancies

Qiuling Wu
Chenjing Qian
Hua Yin
Fang Liu
Yaohui Wu
Weiming Li
Linghui Xia
Ling Ma
Mei Hong

Frontiers in Oncology

doi 10.3389/fonc.2022.897479

3,340 views
10 citations

Original Research

Published on 03 Aug 2021

Genetic Expression Screening of Arsenic Trioxide-Induced Cytotoxicity in KG-1a Cells Based on Bioinformatics Technology

in Predictive Toxicology and Exposomics

Yahui Li
Yingjie Feng
Xiaohui Si
Chenjin Zhao
Fanping Wang
Xinqing Niu

Frontiers in Genetics

doi 10.3389/fgene.2021.654826

3,943 views
2 citations

Original Research

Published on 30 May 2022

Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux

in Molecular and Cellular Oncology

Rachael Nicholson
Ana Catarina Menezes
Aleksandra Azevedo
Adam Leckenby
Sara Davies
Claire Seedhouse
Amanda Gilkes
Steve Knapper
Alex Tonks
Richard L. Darley

Frontiers in Oncology

doi 10.3389/fonc.2022.840046

4,688 views
13 citations

Mini Review

Published on 30 Mar 2022

Perspectives of JAK Inhibitors for Large Vessel Vasculitis

in Autoimmune and Autoinflammatory Disorders

Ryu Watanabe
Motomu Hashimoto

Frontiers in Immunology

doi 10.3389/fimmu.2022.881705

12,920 views
31 citations

Perspective

Published on 11 Nov 2020

UK Experience of an Alternative ATO Dosing Regimen in APL

in Hematologic Malignancies

Nigel Russell
Richard Dillon

Frontiers in Oncology

doi 10.3389/fonc.2020.594129

5,373 views
2 citations

Original Research

Published on 03 Sep 2020

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

in Autoimmune and Autoinflammatory Disorders

Gwen E. Thompson
Lynn A. Fussner
Amber M. Hummel
Darrell R. Schroeder
Francisco Silva
Melissa R. Snyder
Carol A. Langford
Peter A. Merkel
Paul A. Monach
Philip Seo

Frontiers in Immunology

doi 10.3389/fimmu.2020.02053

8,128 views
18 citations

Review

Published on 11 Mar 2021

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol

in Molecular and Cellular Oncology

Miguel Olivas-Aguirre
Liliana Torres-López
Igor Pottosin
Oxana Dobrovinskaya

Frontiers in Oncology

doi 10.3389/fonc.2021.617937

16,055 views
43 citations

Study Protocol

Published on 19 Sep 2024

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis – a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial

in Gastroenterology

Renata Talar-Wojnarowska
Adam Fabisiak
Hubert Zatorski
Katarzyna Płoszka
Katarzyna Błaziak
Wojciech Fendler
Grażyna Rydzewska
Ewa Małecka-Wojciesko
Piotr Eder

Frontiers in Medicine

doi 10.3389/fmed.2024.1458998

6,230 views
5 citations

Articles

The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis

Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice

Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseases

Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment

The Growing Spectrum of DADA2 Manifestations—Diagnostic and Therapeutic Challenges Revisited

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children’s Cancer Group

Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case report

A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients

Genetic Expression Screening of Arsenic Trioxide-Induced Cytotoxicity in KG-1a Cells Based on Bioinformatics Technology

Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux

Perspectives of JAK Inhibitors for Large Vessel Vasculitis

UK Experience of an Alternative ATO Dosing Regimen in APL

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis – a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial